You just read:

IFM Therapeutics, LLC Launches New Subsidiary, IFM Due, to Advance cGAS/STING Antagonists for Serious Inflammatory and Autoimmune Diseases

News provided by

IFM Therapeutics, LLC

Feb 11, 2019, 07:30 ET